Trial Profile
A Multinational, Observational Follow-Up Study of the Incidence of Cancer and Mortality in Patients From the SEAS Trial [EXTENSION OF 700005526]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary)
- Indications Aortic valve stenosis; Cardiovascular disorders
- Focus Adverse reactions; Registrational
- Sponsors Merck Sharp & Dohme Corp.
- 31 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Mar 2013 New trial record